Lumos Diagnostics

Lumos Diagnostics specializes in rapid, cost-effective, and complete point-of-care (POC) diagnostic test technology to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos develops, manufactures, and commercializes novel  POC tests that target infectious and inflammatory diseases. 
FebriDx is a visually read, all-in-one, integrated, single-use test that is designed to assess whether an acute respiratory  infection  is  bacterial  or  non-bacterial  in  origin.  This  test  can  help  aid  clinicians  with  their decisions about antibiotic use and therefore has the potential to improve antibiotic stewardship. 
FebriDx qualitatively detects elevated levels of two proteins created by the body’s immune response that help differentiate between bacterial (C-reactive protein [CRP]) and non-bacterial  (Myxovirus  resistance  protein  A  [MxA])  infections  in  a  fingerstick  blood  sample.